Healthcare Hiring Intelligence.
CMS penalties, regulatory filings, and facility expansions — decoded into executive hiring demand before the mandate exists.
For executive search partners who want to see the hiring landscape before the market does. 34 intelligence entries across 11 healthcare specialisms — the predictive executive search business development intelligence that reveals where facilities are under pressure to hire, why, and when, before a public posting appears.
- 34 intelligence entries across 11 healthcare specialisms
- 100% verifiable data — CMS, HRSA, state regulatory filings
- Healthcare only — built for your specialisms
- One resource — everything in one place
- Why search partner outreach fails
- What makes healthcare uniquely intelligence-rich
- The 4 intelligence categories
- Layering intelligence — where the power lives
- Hospital Executive & Nursing Leadership
- Physician, Pharmacy & Quality
- Behavioral Health & Hospice
- + 8 more specialisms with buyer context
- 20 Distress indicators
- 4 Performance indicators
- 9 Growth indicators
- 1 Event-based indicator
- Match value asset to intelligence type
- 4 email templates with subject lines
- Finding & verifying contact details
- + Domain & email setup
- How to identify active vs inactive prospects
- LinkedIn track — engage before you pitch
- Email track — intelligence-first sequencing
- + Free LinkedIn activity checker tool
- How many intelligence entries to start with
- Daily, weekly, monthly & quarterly cadence
- How to prioritise when intelligence layers
- + Full worked example: intelligence → retained mandate
Most search partner outreach fails because it arrives at the wrong time with the wrong message. Healthcare is different from every other sector because the data that tells you exactly when a facility is under pressure to hire — and why — is publicly available, structured, and updated on a known schedule. The search partners who learn to read this intelligence stop chasing job boards, stop waiting for referrals, stop spraying-and-praying outbound, and start arriving in conversations before anyone else calls — with enough facility-specific context to win retained and exclusive mandates instead of scrapping for contingency.
Why Search Partner Outreach Fails
Most search partners reach out to healthcare facilities with some version of "we're a specialist agency, we'd love to help you with your hiring." Most of the time, they get ignored. Not because the search partner isn't good — but because the timing and the message are wrong.
The timing is random. You're reaching out when there may be no active pain. A VP of HR who isn't currently struggling to fill a critical role has zero incentive to respond to a cold email from an agency they've never heard of.
The pitch is generic. "We specialise in healthcare recruitment" sounds like every other agency that emailed them this month. It tells them nothing about whether you understand their specific situation.
There's no proof upfront. Asking for a call before showing any value puts the burden entirely on the prospect. They don't know you. They don't owe you their time.
The problem isn't capability. It's that you're approaching the right people at the wrong time, with nothing in your hand except a generic promise. Everything changes when you flip that — when you reach out at the exact moment a facility is under pressure, and you lead with specific knowledge of what's driving that pressure.
What Makes Healthcare Uniquely Intelligence-Rich
Healthcare operates under a layer of federal and state regulatory infrastructure that generates structured, public data about every hospital, ASC, behavioral health facility, and health system in the country. This data wasn't designed for search partners. It was designed for compliance, reimbursement, and public accountability. But embedded inside it are indicators that tell you — with remarkable precision — which facilities are about to need leadership talent and why.
When CMS penalises a hospital for clinical safety failures, that penalty is published. When a facility files a new practice location months before it opens, that filing is published. When a provider is federally excluded and must be terminated the same day, that exclusion list is published. When a hospital changes ownership, the date appears in the quarterly federal provider file.
None of this data is secret. All of it is publicly available. And almost no search partners are looking at it.
The competitive advantage isn't access to the data — it's knowing which data to look at, what it means operationally, and how to connect it to a specific hiring need at a specific facility. That connection is what turns a cold pitch into a consultative conversation, and a consultative conversation is what turns contingency work into retained mandates.
The Four Categories of Hiring Intelligence
This guide organises intelligence into four categories based on urgency and how quickly they translate into an active hiring need.
Distress intelligence fires when a facility is under immediate regulatory, financial, or operational pressure. A federal safety penalty. A provider exclusion. A critical role stuck for 60 days. The first credible search partner who arrives with specific knowledge of the situation has a genuine shot at winning the mandate.
Performance intelligence tracks structural shifts that create hiring pressure over a defined window. An ownership change triggers a leadership reshuffle. An interim title confirms a permanent vacancy. A new leader arriving means the team will be reshaped within 90 days.
Growth intelligence tracks expansion indicators. A CON filing. A new satellite clinic registered with CMS. A surgical centre expanding capacity. These tell you hiring is coming 3-6 months before the first job post appears.
Event-based intelligence tracks structural ownership changes — PE acquisitions, hospital conversions — that trigger predictable leadership transitions on a known timeline.
Layering Intelligence: Where the Real Power Lives
Any single indicator is useful. But the real power is what happens when you layer multiple indicators on the same facility.
Consider the difference. You email a VP of HR: "I noticed your Director of Case Management role has been posted for over 60 days." That's valid — but surface-level. Anyone with a LinkedIn account could have noticed.
Now imagine: "Your facility was flagged in the latest CMS readmission penalty data. Your Director of Case Management role has been posted for 60 days and was reposted two weeks ago. And your CNO started three months ago."
That's three indicators layered. The first says regulatory pressure. The second says internal recruitment has failed. The third says there's a new decision-maker. Together, they paint a picture no cold pitch can match.
Layering intelligence is what separates this approach from job-board scraping and spraying-and-praying emails. A single indicator says "this facility might need to hire." Three indicators layered says "this facility is under pressure to hire, their internal process has failed, and here's exactly why."
When you call a hospital armed with that, you're not cold-pitching. You know their quality metrics dropped, or their CNO left two weeks ago, or their Director of Case Management search has been open for 60 days with no fill. That changes how the conversation goes. You're not another agency asking for a job order — you're the search partner who showed up understanding the problem. That's what earns retained and exclusive mandates.
Your Target Market
Everything in this guide assumes you already know which facilities you're tracking. You can't run intelligence against the entire US healthcare market manually — you need a defined target list filtered by geography, facility type, and the specialisms you recruit for.
I've already mapped the entire US healthcare market — every hospital, ASC, and health system — into a searchable database.
If you'd like access to the database for your target geography, just request a free brief — I'll set you up.
Board Chair for CEO searches. Surviving C-suite peer — typically the CNO or CFO — for COO and VP-level searches. COO or VP of Development for new facility openings and expansion roles. PE operating partner for acquisition integration roles. Never approach HR for this specialism — these decisions are made at board and executive level.
CNO for DON and unit-level searches. COO or CEO for CNO searches. CNO or VP of Clinical Operations for care coordination and case management roles. Under distress indicators — IJ citations, HAC penalties, readmission penalties — the CNO is often under pressure themselves, which means the search is owned by the COO or CEO.
CMO for Medical Director and department chief searches. CEO for CMO searches. VP of Medical Affairs for service-line physician leadership. In HRSA shortage situations, the CEO or Executive Director of the FQHC or rural hospital is the right first call.
CFO or COO for quality and compliance director searches. CEO or Board Chair for CCO and General Counsel searches — especially under DOJ or AG investigation. Speed and specificity matter more here than in any other specialism.
CFO or COO. Pharmacy is an operational and financial function — not clinical in most facilities. Never approach the CNO for this specialism — pharmacy does not report into nursing.
CFO in every case. Under bond downgrade or DOJ billing fraud investigation indicators, the CFO is personally under pressure and may be part of the problem — in which case approach the CEO or Board Chair instead.
Chief of Surgery or VP of Surgical Services — not the CNO. This is the key distinction from Specialism 2: ICU and perioperative nursing leadership reports through nursing, but the OR/surgical/anesthesia/cath lab leadership chain reports through the surgical department, not nursing.
CEO or Founder of the organisation in almost every case. Standalone behavioral health organisations at the size your ICP serves are founder or CEO-led with no internal HR function. Either way you reach the decision-maker on the first call.
Executive Director or CEO for founder-led independents. PE operating partner or platform CEO for PE-backed operators. Under termination threat indicators, go directly to Board Chair. Under PE acquisition indicators, approach the PE operating partner not the acquired hospice's founder.
VP or COO of the relevant allied health function. Go one level above the role you're placing — not a generic COO outreach but the specific VP who owns that allied health department.
At a multi-site operator, the VP of Clinical Operations or Regional Director above the facilities owns the search. At a larger standalone facility with no corporate layer, the Administrator or DON directly. Do not approach individual facility staff at small, owner-operated independents.
When the federal government excludes a healthcare provider from Medicare and Medicaid, the employing facility must terminate them the same day. No notice period, no transition plan. The vacancy is immediate, unplanned, and almost never posted publicly in the first days. This is the strongest pre-job-board indicator in healthcare.
Why This Matters
The HHS Office of Inspector General maintains the List of Excluded Individuals and Entities (LEIE). When a provider appears on this list, any facility employing them must terminate their involvement immediately — continuing to bill Medicare for an excluded provider carries penalties of up to $100,000 per item. The exclusion usually comes with no advance warning to the employer.
The operational impact is instant. If the excluded provider was a surgeon performing three days of scheduled procedures per week, those procedures need coverage immediately. Because the termination is involuntary and unplanned, there's no posting on LinkedIn, no job ad on Indeed. For the first days or weeks, the vacancy exists only inside the facility's HR and compliance departments. Any search partner who arrives during this window is the first — and often the only — outside search partner the facility is talking to.
Roles & Who to Contact
Roles This Intelligence Triggers: Physicians (any specialty), Nurse Practitioners, Pharmacists, Clinical Directors, Department Heads.
Who to Approach: Chief Medical Officer, VP of Medical Affairs, or Department Head of the affected specialty. Avoid HR initially — the operational leader feeling the pain is your entry point.
How to Track It
The LEIE is published by HHS-OIG at oig.hhs.gov, updated monthly around the 15th as a downloadable CSV. Filter by state to match your target geography. Cross-reference excluded providers' NPIs against the CMS NPPES database to identify their most recent employer — the facility listed as their practice location now has the vacancy. Check LinkedIn and the facility's career page to confirm no replacement has been posted yet. This takes 2-3 hours per month.
Check whether the facility has other stuck clinical roles (Intelligence 5). A facility dealing with an emergency exclusion AND struggling to fill other positions is overwhelmed — and far more likely to engage on an exclusive or retained basis.
CMS penalises the worst-performing 25% of hospitals for preventable patient harm through the HAC Reduction Program. Penalised hospitals lose 1% of total Medicare payments — millions annually. These hospitals must invest in quality leadership to avoid repeat penalties, creating predictable demand for specific clinical leadership roles.
Why This Matters
The HAC Reduction Program scores every acute care hospital on patient safety indicators: infections (CLABSI, CAUTI, SSI, MRSA, CDI) and safety composites (PSI-90). Hospitals in the bottom 25% receive an automatic 1% Medicare payment reduction — for a mid-size hospital doing $200M in Medicare revenue, that's $2M annually. The penalty resets each year, so repeat penalties indicate systemic failure.
A penalised hospital faces pressure from three directions: the board wants answers, CMS is watching for improvement, and the operational leaders responsible for quality are either being replaced or given ultimatums. This creates demand for quality directors, infection preventionists, patient safety officers, and in severe cases, new nursing leadership who can overhaul unit-level practices.
Roles & Who to Contact
Roles This Intelligence Triggers: VP/Director of Quality and Patient Safety, Infection Prevention Director, Clinical Compliance Director, CNO (in severe or repeat cases), Director of Nursing.
Who to Approach: Chief Nursing Officer, Chief Medical Officer, VP of Quality.
How to Track It
CMS publishes HAC results annually in October on data.cms.gov — search "HAC Reduction Program." Filter for hospitals with Payment Reduction = Yes, cross-reference with your target geography, then check LinkedIn Jobs for open quality or nursing leadership roles. The processing takes 3-4 hours once per year. The intelligence stays relevant until the next results are published.
Cross-reference penalised hospitals against Intelligence 5 (Stuck & Reposted). A hospital penalised for safety failures AND with a Quality Director role open for 60+ days is in serious trouble — their metrics are failing and they can't fill the role that fixes them. That's a retained mandate conversation.
CMS penalises hospitals with excessive 30-day readmission rates through the HRRP. Facilities with readmission ratios above expected levels lose up to 3% of total Medicare reimbursement. This directly pressures hospitals to hire or upgrade leadership in case management, care coordination, and transitional care.
Why This Matters
The HRRP tracks six conditions (heart attack, heart failure, pneumonia, COPD, hip/knee replacement, CABG). Hospitals with Excess Readmission Ratios above 1.0 face graduated penalties up to 3% of Medicare base operating payments — for a $300M Medicare hospital, that's $9M annually. Unlike the flat 1% HAC penalty, the HRRP penalty scales with performance.
Readmission reduction is a care coordination problem. Patients bounce back because post-discharge follow-up failed. Fixing it requires Directors of Case Management, VP-level care coordination leaders, and transitional care specialists. Hospitals with ERRs above 1.15 are actively seeking this leadership.
Roles & Who to Contact
Roles This Intelligence Triggers: Director of Case Management, VP of Care Coordination, Transitional Care Director, Population Health Director.
Who to Approach: CNO, VP of Clinical Operations, or CMO.
How to Track It
Published annually alongside HAC data in October on data.cms.gov — search "Hospital Readmissions Reduction Program." Filter for hospitals with Payment Reduction > 0, then narrow to ERR above 1.15 for highest-priority targets. Same processing time as Intelligence 2: 3-4 hours once per year.
Stack with Intelligence 2. A hospital penalised under BOTH the HAC and HRRP programs is bleeding Medicare revenue from two directions simultaneously. That double penalty is board-level pressure — the facility will be aggressively hiring quality and operational leadership.
This intelligence is high-value if your agency recruits behavioral health or psychiatric nursing leadership. If you don't recruit in this space, skip to Intelligence 5.
CMS tracks quality metrics for inpatient psychiatric facilities including restraint use, seclusion rates, and discharge follow-up. Facilities reporting outlier metrics face accreditation risk and regulatory scrutiny. They need behavioral health nursing and clinical leadership to correct the problems before regulators act.
Why This Matters
The IPFQR program requires psychiatric hospitals to report on restraint hours per patient day, seclusion rates, and post-discharge follow-up. When a facility's rates fall significantly outside norms, it triggers CMS surveyor scrutiny and potential conditions of participation — essentially probation. Excessive restraint use indicates inadequate training, insufficient staffing, or clinical leadership gaps. Fixing it requires experienced behavioral health nursing directors who can overhaul protocols and demonstrate measurable improvement. The talent pool for this leadership is among the thinnest in healthcare.
Roles & Who to Contact
Roles This Intelligence Triggers: Director of Behavioral Health Nursing, Psychiatric Clinical Director, Director of Patient Safety (behavioral health).
Who to Approach: CNO, VP of Behavioral Health Services, or Hospital Administrator.
How to Track It
CMS publishes IPFQR data annually on data.cms.gov. Identify facilities with restraint or seclusion rates significantly above the national median in your target geography. Cross-reference with LinkedIn for behavioral health leadership roles or recent departures.
Check whether the outlier facility has had recent leadership changes (Intelligence 9). A new behavioral health director arriving at a facility with compliance problems is likely to overhaul the team, creating multiple hiring needs.
When a clinical leadership role has been open for 45+ days, or has been taken down and reposted, the facility's internal recruitment process has failed. The pain is proven, the urgency is higher than a fresh posting, and the hiring manager is more receptive to outside help than at any other point.
Why This Matters
Healthcare operates on tight timelines. A Director of Nursing vacancy affects patient ratios. A CMO vacancy creates a governance gap. Past 45 days, the impact is measurable in care metrics, revenue, or compliance. A reposted role tells an even sharper story — the facility ran the search, reviewed candidates, didn't fill it, and started over. Whatever went wrong, they're back at square one with less time and more pressure.
This is the exact moment to arrive — not with a generic pitch, but with evidence you understand what happened. The conversation isn't "let me help you fill this role." It's "your search has been running for 60 days and you reposted two weeks ago — the issue is usually sourcing depth, not the brief itself." That's a retained mandate conversation.
Roles & Who to Contact
Roles This Intelligence Triggers: Any clinical or operational leadership role stuck 45+ days or reposted: Director of Nursing, Clinical Director, Department Heads, CNO, CMO, VP of Operations.
Who to Approach: The hiring manager directly — the person living with the vacant role every day.
How to Track It — Plus a Free Tool
Pull clinical leadership postings weekly from LinkedIn Jobs for your target facilities. Record posting dates. Flag roles past 30 days and 45 days. Track roles that disappear and reappear — those are reposts. Doing this manually for more than a few dozen facilities gets unwieldy fast.
To help, I've built a free tool that gives you a day-0 snapshot of stuck and reposted roles across your target market. Bring your own Apify API key, point it at your geography, and it returns every stuck and reposted clinical role it finds — right now, today.
This tool shows you what's stuck and reposted at the moment you run it. It's a snapshot, not continuous monitoring. For ongoing, desk-level intelligence covering all your target facilities — that's what Foresight Bridge delivers. But the free tool gives you enough to validate the intelligence and see how it works.
This stacks with everything. A stuck role at a penalised hospital (Intelligence 2, 3) is a compound indicator — they can't fill the role that fixes their regulatory problem. A stuck role at a facility going through ownership change (Intelligence 7) tells you integration pressure exceeds capacity. Always check what else is happening.
When a senior clinical or operational leader leaves a facility and no replacement has been posted within two weeks, you're looking at a confirmed vacancy that hasn't hit the public market. This is pre-job-board intelligence at its purest — you arrive before any other search partner knows the role exists.
Why This Matters
A CNO who updates their LinkedIn title to a new employer has just told you — publicly — that their previous facility has a vacancy. The facility, meanwhile, is still deciding whether to restructure the role, promote internally, or search externally. During this 2-4 week window, no external search partner knows the vacancy exists unless they're actively monitoring for it.
Senior healthcare roles cannot stay vacant long. A CNO vacancy means no one is overseeing nursing operations. A CMO vacancy means no one is chairing the medical executive committee. The regulatory and operational consequences of a prolonged gap are severe — the facility will move to fill it. The question is whether you're in the conversation before they've engaged a search firm.
Roles & Who to Contact
Roles This Intelligence Triggers: CNO, CMO, COO, VP of Clinical Operations, Clinical Directors, Department Heads.
Who to Approach: The departed leader's direct superior — typically the CEO, COO, or system-level executive managing the replacement.
How to Track It
Build a list of senior leaders at your target facilities using LinkedIn Sales Navigator. Save them as leads and check weekly for title changes and job change notifications. When a departure is detected, check the facility's career page to confirm no replacement has been posted. For additional confirmation, monitor NPI registry updates — when a provider's practice location changes in NPPES, it confirms they've moved. This takes 30-60 minutes per week for 50-100 facilities.
Check for other stuck roles (Intelligence 5) at the same facility. A facility that just lost its CNO AND has nursing leadership roles stuck for 45+ days is in a compounding talent crisis. Also check for recent ownership changes (Intelligence 7) — departures within 90 days of a CHOW are often integration-related, and more may follow.
An Immediate Jeopardy citation is the most severe finding CMS can issue short of closing a facility. It means a patient was, or is likely to be, seriously harmed due to a leadership or process failure. Facilities under IJ must correct the failure within days — and almost always replace or add clinical leadership as a direct result.
Why This Matters
An IJ citation triggers a chain reaction: CMS notifies the facility, the facility has 24-72 hours to submit a corrective action plan, and the state survey agency returns to verify correction. Failure to correct means termination from Medicare — an existential threat for most hospitals. The board gets involved immediately. Someone at the leadership level is almost always identified as responsible.
This is not a slow-burn financial penalty like HAC or HRRP. The urgency is immediate and the hiring pressure follows within days. A search partner who arrives in the first two weeks — armed with knowledge of the specific citation — is talking to a facility in genuine crisis, not one managing a line item.
The clock is real and short: when a hospital receives an IJ citation, it faces involuntary termination of its Medicare agreement if the deficiency is not corrected within 23 days. That window starts the moment the citation is issued. Leadership replacement is not just a response to pressure — it is often part of the corrective action plan itself, which is why this is the highest-urgency indicator in the playbook.
Roles & Who to Contact
Roles This Intelligence Triggers: DON, CNO, Clinical Director, Unit Manager (of cited department), Administrator, VP Quality, Compliance Officer.
Who to Approach: CNO or Administrator directly. This is not an HR-level conversation.
How to Track It
CMS's public Statement of Deficiencies bulk file only covers nursing homes — it does not include hospital-level Immediate Jeopardy citations in a structured, downloadable format. For hospitals, use QCOR (Quality, Certification & Oversight Reports), CMS's survey lookup tool, filtering by Complaint survey type and Condition-level citations to surface facility-wide failures. Supplement with Exa.ai semantic search and Google Alerts for faster detection between QCOR updates, and watch trade press — Becker's and Modern Healthcare often cover significant IJ citations within days. Once flagged, check LinkedIn for leadership changes at that facility in the last 30 days. Takes 1-2 hours per month.
Cross-reference with Intelligence 5 (Stuck & Reposted). A facility with an IJ citation AND a clinical leadership role open for 45+ days is in a compounding crisis — the vacancy may be contributing to the IJ finding itself. That is a retained mandate conversation.
When Moody's, S&P, or Fitch downgrades a hospital's bond rating or revises its outlook to negative, it indicates financial distress that almost always reaches the C-suite. Boards respond by replacing or strengthening financial and operational leadership — CFO, CEO, COO, VP of Revenue Cycle. The rating action is public. The hiring pressure is immediate. And almost no search partners are watching for it.
Why This Matters
Hospitals that issue municipal bonds are subject to ongoing credit surveillance. A downgrade means the rating agency has determined the facility's financial position has materially deteriorated — thin margins, rising debt, declining volumes. The board reads the same report. The CFO who presided over the deterioration is the first person under scrutiny.
This is a slow-burn indicator, not a move-fast one. The immediate response to a downgrade is almost always a hiring freeze to preserve cash — not a leadership search. Leadership replacement typically follows 3-6 months later, after the board has completed an internal review. The value of this indicator is early warning, not an open door: detect it now, monitor the facility over the following quarter, and move when Intelligence 06 (Leadership Exit) or Intelligence 08 (Interim Appointment) confirms the departure is real.
Roles & Who to Contact
Roles This Intelligence Triggers: CFO, CEO, COO, VP of Revenue Cycle, VP of Finance, Chief Strategy Officer.
Who to Approach: Not the Board Chair, and not right after the downgrade. Boards in financial distress work with established executive search firms for CEO-level crisis hires — a cold approach referencing the downgrade directly reads as predatory, not informed. Use the downgrade to start watching the facility, not to start calling. Once Intelligence 06 or Intelligence 08 confirms a departure, approach the surviving C-suite peer (CFO or COO) for the search that follows.
Read the Driver, Target the Role
The rating action report states the reason for the downgrade. That reason tells you exactly which role is under the most pressure — read it before deciding who to approach.
"Persistent labor costs / weak volume" → COO or CNO. This is a staffing and agency cost problem.
"Delays in accounts receivable / IT implementation" → VP of Revenue Cycle or Health IT Director. The billing system is broken.
"Declining patient volumes / market share loss" → Chief Strategy Officer or VP of Business Development.
"Debt covenant breach / depleted cash reserves" → CFO or VP of Finance.
How to Track It
Rating action summaries are published free on agency websites and covered in trade press. Use Exa.ai for weekly semantic search across rating summaries, Becker's, Modern Healthcare, and bond newsletters. Supplement with EMMA (emma.msrb.org) — the free municipal bond disclosure database. Takes 20-30 minutes per week.
Cross-reference with Intelligence 6 (Leadership Exit). A bond downgrade followed within 60 days by a CFO or CEO departure confirms the board acted — the permanent search is either underway or about to launch.
Highest value for agencies placing compliance and pharmacy leadership. If your agency doesn't recruit in these areas, this intelligence may not be relevant to your practice.
When HRSA audits find a hospital misusing the 340B drug discount program, the facility faces repayment demands, corrective action requirements, and potential program termination. Fixing it requires strengthening pharmacy and compliance leadership — roles that are senior, permanent, and placement-worthy.
Why This Matters
The 340B program allows eligible hospitals to purchase outpatient drugs at significantly discounted prices — worth tens of millions annually for large systems. HRSA audits and publishes findings publicly. A violation means incorrect billing, diversion, or inadequate oversight. The corrective action plan almost always includes strengthening pharmacy compliance and often replacing the leadership responsible. These are niche roles that generalist search partners cannot fill — but a executive search firm with healthcare compliance placement experience is exactly who the facility needs.
Roles & Who to Contact
Roles This Intelligence Triggers: Director of Pharmacy, Chief Compliance Officer, VP of Revenue Integrity, 340B Program Director.
Who to Approach: CFO or Chief Compliance Officer.
How to Track It
HRSA publishes 340B audit findings on hrsa.gov under the 340B Drug Pricing Program audit results page — updated quarterly. Filter for hospitals with violation findings and cross-reference against your target geography. Takes 1-2 hours quarterly.
Cross-reference with Intelligence 19 (Bond Rating Downgrade). A hospital under financial pressure AND a 340B violation is facing a revenue integrity crisis from two directions — the case for a retained CCO search writes itself.
When a skilled nursing facility drops one or more stars on the CMS Five-Star Quality Rating System, it indicates a clinical and operational leadership failure visible to every family choosing a facility. For a single independent facility, this is a local problem the Administrator absorbs directly. For a multi-site operator, a rating drop — especially one repeated across several facilities — is a portfolio-level problem the corporate clinical team owns. Published quarterly by CMS and free to access.
Why This Matters
The Five-Star rating is the primary tool families use to evaluate SNFs. A drop from 4 to 3 stars has a direct impact on census — occupancy rates fall within one to two quarters. For a facility billing $300-500 per patient day, a 10% occupancy drop is millions in lost revenue. At a single facility, this is an Administrator-level problem. At a multi-site operator, look for the pattern: if two or more facilities in the same portfolio drop in the same quarter, that is a systemic clinical leadership failure at the regional or corporate level, not a local one.
The rating has three components: health inspections, staffing levels, and quality measures. A drop driven by staffing across multiple sites indicates a regional staffing or recruitment failure. A drop driven by quality measures across multiple sites indicates a gap in corporate clinical oversight. The specific component, multiplied across facilities, tells you exactly which corporate role is under pressure.
Roles & Who to Contact
Roles This Intelligence Triggers: VP of Clinical Operations, Regional Director of Clinical Services, Regional Director of Nursing, VP of Quality & Compliance (corporate). For larger standalone facilities with no parent operator, Director of Nursing or Administrator directly.
Who to Approach: At a multi-site operator, go to the VP of Clinical Operations or Regional Director above the facilities — they own the portfolio-wide pattern, not the facility-level Administrator. At a larger standalone facility with no corporate layer, approach the Administrator or DON directly. Do not approach individual facility staff at small, owner-operated independents — there is no search mandate at that level.
How to Track It
CMS publishes Five-Star ratings on Care Compare and as a downloadable dataset on data.cms.gov under "Nursing Home Compare." Updated quarterly. Compare star ratings against the previous quarter, flag drops, and group by parent operator — CMS ownership data lets you map facilities to the same corporate entity. A single facility drop is a local lead; two or more drops in the same portfolio in the same quarter is a corporate-level mandate. Takes 2-3 hours quarterly.
Check Intelligence 06 (Leadership Exit) and Intelligence 08 (Interim Leader). A multi-site operator with a portfolio-wide rating drop AND an interim or vacant Regional Director of Nursing is in a self-reinforcing crisis — the leadership gap is likely driving the rating decline across sites.
When a hospital receives a Civil Investigative Demand from the DOJ or is named in a False Claims Act investigation, it triggers an immediate compliance leadership response. CCOs, VP of Legal, and VP of Risk are the first roles affected. These actions are announced publicly and almost no search partners track them.
Why This Matters
A Civil Investigative Demand is a federal subpoena — the DOJ is formally investigating potential fraud against federal healthcare programs. False Claims Act penalties reach up to three times the fraudulent amount plus $27,000 per claim. Exposure can reach nine figures for large systems. The board convenes, outside counsel is engaged, and the internal compliance function is immediately under review.
The hiring is fast and senior. A facility under federal investigation needs a CCO who has navigated this before. They need a VP of Legal with healthcare enforcement experience. These mandates are almost always retained because the stakes are too high for contingency.
Roles & Who to Contact
Roles This Intelligence Triggers: Chief Compliance Officer, VP of Legal / General Counsel, VP of Risk Management, VP of Revenue Integrity.
Who to Approach: CEO or Board Chair directly. At this level of legal exposure, the board is involved.
How to Track It
DOJ announces via justice.gov press releases. State AG offices publish on their own websites. Use Exa.ai for weekly semantic search across DOJ releases, state AG announcements, and trade press. Becker's covers significant cases within days. Takes 20-30 minutes per week.
Cross-reference with Intelligence 6 (Leadership Exit). A DOJ investigation followed by a CCO or GC departure within 30-60 days confirms the board acted. Stack with Intelligence 19 (Bond Downgrade) for compound crisis — the leadership overhaul will be broader than a single role.
USP 797 and USP 800 are the national standards every hospital pharmacy must follow for sterile and hazardous drug compounding. State boards of pharmacy inspect hospital pharmacies against these standards and publish violations publicly. A cited facility must remediate immediately — and the Director of Pharmacy is the person held accountable. Almost no search partners monitor state board inspection results.
Why This Matters
USP 797 governs sterile compounding — IV preparations, chemotherapy admixtures, epidural injections. USP 800 governs hazardous drug handling — cytotoxics, antineoplastics, anything that poses a risk to staff or patients if mishandled. A violation in either standard is not a paperwork failure. It is a patient safety failure with direct liability consequences for the facility and the Director of Pharmacy personally.
State boards of pharmacy have the authority to suspend a hospital pharmacy's operating license, which would halt all inpatient medication dispensing. Facilities cited for USP violations move fast: the Director of Pharmacy is either given a remediation plan to execute or replaced. In cases where the violations are systemic — multiple findings across sterile prep, beyond-use dating, environmental monitoring — replacement is the more common outcome. The citation is public, the accountability is clear, and the hiring window is short.
Roles & Who to Contact
Roles This Intelligence Triggers: Director of Pharmacy, Associate Director of Pharmacy, Director of Pharmacy Compliance, Sterile Compounding Manager.
Who to Approach: CFO or COO — pharmacy is an operational and financial function at the facility level. The CNO is a secondary contact if the violations touch clinical care delivery directly.
How to Track It
Every state board of pharmacy publishes inspection results and enforcement actions on its website. Consistency varies by state — some publish searchable databases, others publish PDFs monthly. Focus on the states where your ICP agencies operate and bookmark the relevant board pages. Set a monthly calendar reminder to check each one. Supplement with Google Alerts for "hospital pharmacy USP 797 violation [state]" to catch trade press coverage of significant actions. Takes 30-45 minutes per month per state once the pages are bookmarked.
Cross-reference with Intelligence 27 (State Board License Action). A USP violation that escalates to a formal license action against the facility is a compound indicator — the Director of Pharmacy departure is now near-certain. Stack both indicators and reach out the moment the license action is published, not just the initial inspection finding.
The Joint Commission accreditation standards include a dedicated Medication Management chapter. When a hospital receives a Requirement for Improvement specifically in the MM chapter, it isolates the pharmacy function as the source of the failure — more precise than a general accreditation warning. The finding is published on the Joint Commission's Quality Check portal and triggers an immediate internal review of pharmacy leadership.
Why This Matters
A Joint Commission MM finding is not a general compliance warning — it is a specific, documented failure in how the facility procures, stores, prepares, dispenses, or monitors medications. The Joint Commission scores each finding by risk level. High-scoring MM findings — those rated as Immediate Threat to Health or Safety — carry the same urgency as a CMS Immediate Jeopardy citation for the pharmacy function specifically.
The reason this indicator is more precise than a general accreditation finding is the chapter specificity. A hospital can receive Requirements for Improvement across multiple chapters — environment of care, infection control, nursing — and pharmacy leadership may not be touched. An MM chapter finding means pharmacy is the problem. That specificity gives you a cleaner and more credible outreach hook than a general accreditation warning.
Roles & Who to Contact
Roles This Intelligence Triggers: Director of Pharmacy, Director of Clinical Pharmacy, VP of Pharmacy Services, Director of Pharmacy Informatics (if the finding relates to medication order entry or EHR integration failures).
Who to Approach: COO or CNO — the Joint Commission corrective action process is typically owned at the operational leadership level, not by HR.
How to Track It
The Joint Commission publishes accreditation status and findings by facility on Quality Check (qualitycheck.org) — publicly searchable by hospital name or geography. Filter for hospitals with current Requirements for Improvement and cross-reference the finding chapters. Any facility with an open MM chapter finding is in scope. The portal updates on a rolling basis as surveys are completed. Takes 1-2 hours monthly to review new survey results for your target geography.
Cross-reference with Intelligence 24 (USP 797/800 Violation). A facility with both a Joint Commission MM finding and an active USP violation is failing on two separate oversight frameworks simultaneously — that is a systemic pharmacy leadership failure, not an isolated incident. The case for a Director of Pharmacy replacement is overwhelming and the retained search conversation is straightforward.
A Never Event is a serious, preventable patient safety failure that should never occur in a well-managed facility. Medication-related Never Events — wrong drug, wrong dose, wrong patient resulting in serious harm or death — implicate both pharmacy and clinical leadership simultaneously. CMS does not reimburse for Never Events and state health departments publish them. The hiring pressure falls on two leadership tracks at once.
Why This Matters
A medication Never Event is the most severe outcome a pharmacy failure can produce. It means a patient was seriously harmed or died because of a medication error that proper systems and leadership should have prevented. CMS introduced non-payment for Never Events in 2008 — the financial hit is immediate. State health departments require mandatory reporting and publish the events, which means the failure is visible to regulators, accreditors, patients, and the press simultaneously.
The leadership response is always dual-track. The Director of Pharmacy is accountable for the dispensing system failure. The clinical leadership — CNO, Clinical Director, or the relevant department head — is accountable for the administration failure. Both tracks are reviewed. Both may result in replacement. This is the only indicator in the playbook that reliably opens two senior search conversations at the same facility from a single event.
Roles & Who to Contact
Pharmacy track — Roles: Director of Pharmacy, Director of Medication Safety, VP of Pharmacy Services.
Clinical track — Roles: CNO, Clinical Director of the affected department, VP of Patient Safety, Chief Quality Officer.
Who to Approach: CEO directly. A medication Never Event is a board-level event — the CEO is managing the response personally. Approaching at CEO level demonstrates that you understand the severity and are not treating this as a routine vacancy.
How to Track It
State health departments publish Serious Reportable Events (the formal term for Never Events) through their patient safety or quality reporting programs. Each state uses slightly different terminology — New York calls them "Serious Adverse Events," Pennsylvania uses "Serious Events," Minnesota publishes an annual Adverse Health Events report. Identify the reporting portal for each state in your target geography and check monthly. Supplement with Exa.ai running a weekly semantic search for "medication error never event hospital [state] 2026" to catch press coverage of significant events before the state report is published. Takes 1-2 hours monthly per state.
Lead with the clinical track in your first outreach — frame around patient safety leadership rather than pharmacy specifically. Once the conversation is open, the pharmacy director vacancy will surface naturally. Approaching pharmacy-first can feel transactional given the severity of the event. Approaching safety-first positions you as a strategic partner, not a vacancy filler.
Cross-reference with Intelligence 15 (CMS Immediate Jeopardy). A facility that receives an IJ citation following a medication Never Event is under the most severe regulatory pressure possible — CMS, state health department, and potentially Joint Commission all active simultaneously. That is a multi-role, retained-only engagement and the conversation starts at board level, not department head level.
State boards of pharmacy can take formal action against a hospital pharmacy's operating license — not just against individual pharmacists. A facility-level license action means the failure is systemic, not individual. It is the most severe action the state board can issue and almost always results in Director of Pharmacy replacement. Published on every state board's enforcement page and monitored by almost no search partners.
Why This Matters
There is an important distinction between a state board action against an individual pharmacist's license and an action against the facility's pharmacy operating license. Individual sanctions happen regularly and do not necessarily trigger leadership change. A facility-level action — probation, conditional license, suspension — is categorically different. It means the board has determined the failure is institutional: the systems, processes, and oversight that the Director of Pharmacy is responsible for have broken down to the point where the facility's right to operate a pharmacy is in question.
The financial consequence of a pharmacy license suspension at a hospital is catastrophic — all inpatient medication dispensing halts. No facility allows this situation to persist with the same leadership in place. A facility-level pharmacy license action is the single clearest indicator that a Director of Pharmacy search is either underway or about to launch. It is more direct than any other pharmacy indicator in this playbook.
Roles & Who to Contact
Roles This Intelligence Triggers: Director of Pharmacy, VP of Pharmacy Services, Chief Pharmacy Officer (in systems large enough to have one), Associate Director of Pharmacy (if the Director is retained and a deputy is added to strengthen oversight).
Who to Approach: CFO or COO. The pharmacy license is an operational asset — the CFO owns the financial risk and the COO owns the operational remediation. This is not a CNO conversation unless the action touches clinical care delivery directly.
How to Track It
Every state board of pharmacy publishes enforcement actions on its website. The key distinction to filter for is actions against facilities or institutional permits — not actions against individual pharmacist licenses. Language varies by state: look for "institutional pharmacy," "hospital pharmacy permit," "facility license," or "permit action" rather than individual name-based entries. Most state boards update their enforcement pages monthly. Bookmark the enforcement section of each relevant state board and check monthly. Takes 20-30 minutes per state per month. For states with poorly organised databases, set a Google Alert for "[state] board of pharmacy hospital license action" as a supplement.
A facility-level license action almost always follows an earlier inspection finding or USP violation (Intelligence 24) that went unresolved. If you were tracking Intelligence 24 for this facility and the situation escalated to a license action, you have context no other search partner has — you watched the failure develop in real time. Lead your outreach with that timeline: "I've been following the pharmacy compliance situation at your facility since the USP finding in [month] — I work with pharmacy directors who have specific experience remediating these situations." That is a conversation no cold caller can replicate.
SAMHSA certifies every Opioid Treatment Program in the US — methadone clinics, MAT providers, addiction treatment centres dispensing controlled substances. When SAMHSA withdraws or suspends a certification, the facility cannot legally operate. The Medical Director is almost always directly implicated. Published by SAMHSA and fires with immediate urgency. Almost no search partners monitor this database.
Why This Matters
An OTP certification is not optional — it is the legal basis on which a facility dispenses methadone, buprenorphine, and other Schedule II substances for addiction treatment. SAMHSA issues certification withdrawals when facilities fail to meet federal opioid treatment standards: inadequate physician oversight, failure to maintain required counselling ratios, improper dispensing practices, or medical director non-compliance. Without the certification, the facility must stop dispensing immediately.
The Medical Director of an OTP carries personal federal responsibility for the program's compliance. A SAMHSA certification withdrawal almost always names the Medical Director's failures in the findings. The organisation must either remediate under the same Medical Director — which SAMHSA rarely accepts — or appoint new physician leadership as part of the corrective action plan. This is the most direct and unambiguous leadership replacement indicator in the behavioral health segment.
Roles & Who to Contact
Roles This Intelligence Triggers: Medical Director, Chief Medical Officer, Chief Clinical Officer, Director of Addiction Services.
Who to Approach: CEO or Executive Director of the OTP organisation. These are founder-led or PE-backed operators — the CEO owns the regulatory relationship with SAMHSA and is personally managing the corrective action. Do not approach HR.
How to Track It
SAMHSA maintains the Opioid Treatment Program Directory and publishes certification actions on samhsa.gov under the Opioid Treatment Program Certification section. Formal withdrawal actions are also published through the Federal Register. Set up a Google Alert for "SAMHSA opioid treatment program certification withdrawal" and check the SAMHSA OTP directory monthly for status changes. Supplement with Exa.ai running a weekly search for "SAMHSA OTP certification suspended [state] 2026" to catch trade press and local news coverage of significant actions. Takes 20-30 minutes per week once the workflow is set up.
Cross-reference with Intelligence 29 (State Behavioral Health License Action). An OTP that loses its SAMHSA federal certification often simultaneously triggers a state license review — two separate regulatory bodies acting on the same failure. That compound indicator means the CEO is managing multiple corrective action timelines at once and is highly motivated to resolve the leadership gap fast.
Every state licenses standalone behavioral health facilities — psychiatric hospitals, addiction treatment centres, outpatient mental health networks — through a dedicated behavioral health authority separate from the hospital licensing board. A formal license action against a facility means the state has determined the failure is systemic and leadership-driven. Published monthly by each state's behavioral health authority and monitored by almost no search partners.
Why This Matters
State behavioral health license actions are distinct from hospital license actions and from individual clinician sanctions. They target the facility's operating license — the legal permission to provide behavioral health services. Actions range from conditional licenses and corrective action plans to full suspension. At any level, the state is telling the organisation that its clinical or operational leadership has failed to meet the standards required to serve a vulnerable population.
The buyer response is predictable: the CEO engages outside counsel, submits a corrective action plan, and reviews the leadership responsible for the failure. Chief Clinical Officer, Medical Director, and Director of Operations are the most commonly implicated roles. Unlike hospital license actions which often involve large bureaucracies, behavioral health organisations are typically smaller and founder or CEO-led — meaning the decision to replace leadership is faster and less political.
Roles & Who to Contact
Roles This Intelligence Triggers: Chief Clinical Officer, Medical Director of Psychiatry, Director of Operations, Director of Addiction Services, Regional Clinical Director.
Who to Approach: CEO or Founder directly. Behavioral health organisations at the size your ICP serves are almost always founder or CEO-led. The CEO is the person managing the state relationship and the corrective action — they are the right first call.
How to Track It
Each state's behavioral health authority publishes enforcement actions on its website. The agency name varies by state — it may sit under the Department of Health, Department of Human Services, or a standalone Office of Mental Health. Identify the relevant agency for each state in your target geography and bookmark their enforcement or licensing action pages. Most update monthly. Focus on facility-level actions rather than individual clinician sanctions. Set up Google Alerts for "[state] behavioral health facility license action" as a supplement. Takes 30-45 minutes per state per month once the pages are bookmarked.
Check LinkedIn for interim titles at the organisation within 30 days of the license action. An interim CCO or interim Medical Director appearing confirms the permanent search is imminent. Stack with Intelligence 5 (Stuck & Reposted) — a behavioral health organisation under a license action that is also advertising a CCO role with no fill after 45 days is in a compounding crisis that no internal process is going to resolve.
CMS surveys hospice agencies against federal Conditions of Participation. A Condition-level deficiency — the most severe finding short of termination — means the agency has failed a fundamental federal requirement for patient care, clinical oversight, or governance. It is not a paperwork failure. It is a leadership failure. Published through CMS survey data and triggers mandatory corrective action with a defined deadline. Almost no search partners monitor hospice survey findings.
Why This Matters
CMS Conditions of Participation for hospice cover the core obligations of a Medicare-certified agency: patient rights, initial and comprehensive assessments, care planning, quality assessment and performance improvement, and clinical leadership oversight. A Condition-level deficiency means CMS has determined the agency is failing at one of these fundamental requirements — not at a procedural standard but at the core of what hospice care is supposed to deliver.
The finding triggers a mandatory Plan of Correction with a defined submission deadline. CMS returns to verify the correction has been made. If it hasn't, the agency faces termination from Medicare. In this environment, the Executive Director and Chief Clinical Officer are directly accountable. Boards of smaller hospice organisations respond fast — they cannot afford the reputational damage of a publicised CMS finding in a business that runs entirely on referral relationships with hospitals, physicians, and families. A Condition-level deficiency at a hospice is the equivalent of an Immediate Jeopardy citation at a hospital — urgent, public, and almost always followed by leadership review.
Roles & Who to Contact
Roles This Intelligence Triggers: Chief Clinical Officer, Executive Director, Director of Clinical Services, Medical Director of Hospice, Director of Quality.
Who to Approach: Board Chair or CEO directly. For founder-led independent hospices, the founder is both the CEO and the person managing the CMS relationship. For PE-backed operators, the regional VP or operating partner is the right contact — they are the ones holding the Executive Director accountable.
How to Track It
CMS publishes hospice survey deficiency data through the Hospice Compare dataset on data.cms.gov — downloadable and updated quarterly. Filter by deficiency type to isolate Condition-level findings from standard deficiencies. The dataset includes the facility name, location, survey date, and deficiency tag. Cross-reference the tag number against the Hospice Interpretive Guidelines to understand which Condition was cited — this tells you which leadership role is accountable. Supplement with Exa.ai running a monthly search for "hospice CMS deficiency condition level [state] 2026" to catch trade press coverage. Takes 1-2 hours quarterly to process the dataset update.
Cross-reference with Intelligence 36 (Hospice Compare Star Rating Drop). A hospice with a Condition-level deficiency AND a recent star rating drop is failing on two separate CMS measurement frameworks simultaneously. That compound indicator means referral partners — hospitals, oncologists, primary care physicians — are already seeing the quality data and pulling back. The organisation is under commercial and regulatory pressure at the same time. That is a retained search conversation, not a contingency one.
Every state licenses hospice agencies separately from CMS Medicare certification. A state license action — conditional license, probation, or suspension — sits on top of any federal findings and represents a second, independent regulatory body determining the organisation has failed. Published monthly by each state's health department and monitored by almost no search partners.
Why This Matters
State hospice licensing requirements often exceed federal CMS standards — states can impose additional staffing ratios, clinical documentation requirements, or governance standards that CMS does not mandate. A state license action means the organisation has failed these higher-bar requirements. It also means the hospice is now managing two separate regulatory relationships simultaneously — CMS and the state — each with its own corrective action timeline and inspection schedule.
For smaller founder-led hospices, managing dual regulatory actions is beyond the capacity of the existing leadership team. The CEO is consumed by compliance. The Clinical Director is writing corrective action plans. Operations are suffering. This is the moment when outside expertise — in the form of new clinical or operational leadership — becomes not just desirable but necessary. A state license action on top of existing CMS findings is the clearest possible indicator that the current leadership team cannot resolve the situation alone.
Roles & Who to Contact
Roles This Intelligence Triggers: Executive Director, Chief Clinical Officer, Director of Clinical Services, Director of Operations, Director of Quality and Compliance.
Who to Approach: CEO or Founder for independent hospices. Regional VP or PE operating partner for multi-site operators. The state license is an operational asset — the operational leader owns the relationship with the state licensing body.
How to Track It
State health departments publish hospice license enforcement actions on their websites — typically under the same licensing enforcement section as hospital and nursing home actions. Search for "hospice" within the facility type filter. Most states update monthly. Identify the relevant section for each state in your target geography and check monthly. State actions sometimes precede CMS findings — monitoring at state level gives you an earlier window than waiting for the federal dataset to update. Takes 20-30 minutes per state per month once the pages are bookmarked.
Cross-reference with Intelligence 32 (CMS Condition-Level Deficiency). A hospice managing both a CMS Condition-level finding and a state license action simultaneously is in the most severe regulatory position possible short of termination. Approach at board level, not CEO level — at this point the board is actively involved in the leadership review and may be more accessible and more motivated than the CEO who is managing the crisis day to day.
When CMS issues a termination notice to a hospice — the final step before removal from the Medicare program — the organisation has days to weeks to demonstrate it has corrected the underlying failures. Medicare is 90%+ of revenue for most hospices. Termination is existential. The board intervenes immediately and leadership change at the most senior level is almost certain. Published through CMS enforcement actions and widely covered in trade press.
Why This Matters
A CMS termination notice is the end of a regulatory escalation that started with survey deficiencies. By the time CMS issues a termination notice, the hospice has already failed to correct its deficiencies through the standard Plan of Correction process. The board is now in emergency session. Outside counsel is engaged. The immediate question is not just how to fix the compliance failures — it is whether the current leadership team is capable of fixing them at all.
The answer is almost always no. A hospice that has escalated to termination notice stage under the current Executive Director and CCO has demonstrated that those leaders cannot resolve the situation. The board's only viable path is new leadership — someone who has navigated CMS termination situations before and can credibly represent to the surveyors that the organisation has fundamentally changed. This is the highest-urgency indicator in the hospice segment and almost certainly leads to a retained search for Executive Director and CCO simultaneously.
Roles & Who to Contact
Roles This Intelligence Triggers: Executive Director, Chief Clinical Officer, Director of Clinical Services, Medical Director of Hospice — all potentially in scope simultaneously.
Who to Approach: Board Chair directly. At termination notice stage the board has taken control of the situation from the CEO. The Board Chair is the decision-maker on leadership change. This is one of the few indicators in the entire playbook where bypassing the CEO and going directly to the board is not just acceptable but strategically correct.
How to Track It
CMS publishes Medicare termination actions through the CMS Survey & Certification Enforcement database on data.cms.gov. Termination notices for hospices are also covered by Hospice News, McKnight's Home Care, and regional healthcare trade press — often within days of the notice being issued. Set up Exa.ai running a weekly search for "hospice Medicare termination CMS [state] 2026" to catch both the official publication and trade press coverage simultaneously. This indicator is rare enough that when it fires it deserves immediate attention — prioritise above all other outreach for that week. Takes 20-30 minutes per week to monitor.
A hospice at termination notice stage has almost certainly been visible in Intelligence 32 and 33 for months before escalating here. If you have been tracking those earlier indicators and have context on this organisation's regulatory history, lead with that in your board outreach — "I've been following the CMS situation at [organisation] since the Condition-level finding in [month]." That timeline awareness demonstrates credibility that no cold outreach can replicate and positions you as someone who has been thinking about this problem longer than the board has been in crisis mode.
When a hospital changes ownership — acquisition, merger, or PE roll-up — the new owners almost always reshuffle leadership within 90-180 days. This creates a predictable wave of executive and clinical leadership vacancies. CMS records every ownership change in a federal database, often before it hits the news.
Why This Matters
A change of ownership (CHOW in CMS terminology) triggers a mandatory update to Medicare provider enrollment, recorded in the CMS Provider of Services file. New owners bring their own strategic vision and leadership preferences. C-suite changes happen in the first 30-60 days. Department heads and directors follow in the 60-180 day window. Service line roles emerge over 3-12 months.
The acquired facility's internal TA function is often one of the first things absorbed or eliminated in a merger — so the hiring surge hits exactly when the facility has the least internal capacity to manage it. A search partner who gets in at the 30-day mark can position themselves for the entire cascade.
Roles & Who to Contact
Roles This Intelligence Triggers: CEO, CFO, COO (first wave). CNO, CMO, VP of Operations (second wave). Department Heads, Service Line Directors (third wave).
Who to Approach: Acquiring system's CHRO or VP of Talent (first wave). Surviving operational leaders at the acquired facility (second/third wave).
How to Track It
Early detection: Monitor Becker's Hospital Review, Modern Healthcare, and Levin Associates for M&A announcements. Set Google Alerts for healthcare acquisitions in your geography.
Confirmation: Download the CMS POS file quarterly from data.cms.gov. Compare "Owner Type" and "Ownership Change Date" fields against the previous quarter. Any facility with a new date has undergone a CHOW. Quarterly processing takes 2-3 hours combined with Intelligence 12 analysis (same file).
Check for interim titles (Intelligence 8) at the acquired facility. An interim appointment within 60 days of a CHOW confirms the new owners created a vacancy — the permanent search is coming. Also check for leadership exits (Intelligence 6) — departures within 90 days of a CHOW indicate more turnover ahead.
When someone takes on an Interim, Acting, or Temporary title at a healthcare facility, it means one thing: there is a confirmed permanent vacancy that hasn't been filled. The facility has plugged the gap short-term. The permanent search is either underway or about to begin.
Why This Matters
An interim title is an institutional acknowledgment of a permanent vacancy. The person in the acting role is usually doing two jobs. They may not want the permanent role or be qualified for it. The pressure to resolve the interim builds over time — manageable at 30 days, strained at 60, actively searching at 90.
A search partner who reaches out during the 30-60 day window — after the interim appointment but before the formal search launches — can influence how the search is structured. "You have an interim CNO. You'll need a permanent search in the next 30-60 days. I can run it exclusively and have a shortlist ready before your interim arrangement becomes unsustainable." That's how retained mandates are won.
Roles & Who to Contact
Roles This Intelligence Triggers: Any senior role with an interim appointment: Interim CNO, Acting CMO, Interim Director of Nursing, Acting VP of Operations.
Who to Approach: The person the interim leader reports to — typically CEO or COO. The interim leader themselves may also welcome help accelerating the search.
How to Track It
Using LinkedIn Sales Navigator, save senior leaders at your target facilities as leads. Review title change notifications weekly and filter for "Interim," "Acting," "Temporary," or "ad interim." Check the facility's career page to see whether a permanent search has been posted. This takes 20-30 minutes per week for 50-100 facilities.
Check for ownership changes (Intelligence 7). An interim CNO installed within 60 days of a CHOW means the new owners replaced the previous leader and are looking for their own candidate — high-urgency retained search with a defined buyer.
When a new CNO, CMO, COO, or Clinical Director joins a facility, they almost always reshape their team within 90 days. The first 90-day window after a senior appointment is one of the most predictable hiring triggers in healthcare.
Why This Matters
New leaders assess the existing team, identify capability gaps, and make decisions about who stays and who gets replaced. The pattern is so predictable it has an informal name: the "100-day plan." The hiring pressure builds over 90 days: assessing in the first 30, deciding between 30-60, executing between 60-90.
A search partner who reaches out within 30 days can position as a resource for the upcoming wave. The pitch is speculative in a way distress indicators aren't — not every new leader reshuffles — but when it converts, it often generates multiple placements because the reshuffle creates several vacancies at once.
Roles & Who to Contact
Roles This Intelligence Triggers: Depends on the new leader. New CNO → nursing leadership. New CMO → medical staff leadership. New COO → operational leadership.
Who to Approach: The new leader directly. They're the decision-maker and open to relevant market conversations in their first 90 days.
How to Track It
Monitor LinkedIn for new appointments at your target facilities — filter for external hires, not internal promotions. Hospital press releases and Becker's cover senior appointments at larger systems. When detected, note the start date and set a 30-day follow-up. This takes 15-20 minutes per week.
Check whether the previous leader departed suddenly (Intelligence 6). A new leader replacing a pressured departure is far more likely to make aggressive changes. Also check for penalty pressure (Intelligence 2, 3) — a new CNO at a HAC-penalised hospital was almost certainly brought in to fix quality metrics.
Highest value for agencies placing rural health administrators and clinical directors. If your agency doesn't recruit in rural health settings, this intelligence may not be relevant.
When a critical access hospital converts to a Rural Emergency Hospital — a CMS designation introduced in 2023 — it fundamentally changes its service model, eliminating inpatient beds and restructuring around emergency and outpatient care. Every conversion triggers a leadership restructure. The conversions are published by CMS and almost no search partners are tracking them.
Why This Matters
The REH designation prevents rural hospital closures by offering a financially viable alternative model. A converting facility must eliminate inpatient services, redesign clinical workflows, and restructure leadership. Leaders whose roles were built around inpatient operations either transition or depart. New roles emerge: Emergency Services Director, Outpatient Clinical Director, and a new Administrator. Almost no executive search firms have built any intelligence around this. A facility mid-conversion is dealing with a leadership gap at exactly the moment its internal HR capacity is most stretched.
Roles & Who to Contact
Roles This Intelligence Triggers: Administrator, Emergency Services Director, Outpatient Clinical Director, DON (restructured scope), CFO, CMO.
Who to Approach: CEO or Board Chair of the converting facility — small, community-governed organisations where the board is directly involved.
How to Track It
CMS publishes the list of approved and converting REH facilities on cms.gov under the Rural Emergency Hospital provider page. Download monthly and compare. Supplement with Google Alerts for "rural emergency hospital conversion [state]." Takes 20-30 minutes per month.
Check for interim titles (Intelligence 8) at the converting facility. An interim Administrator or DON within 60 days of conversion confirms the restructure has created vacancies — position for all of them at once.
When a healthcare organisation registers a new practice location with CMS months before it opens, that registration is captured in a federal database. Most search partners won't hear about the new clinic until it opens or the job posts appear. You can be in the conversation 3-6 months earlier.
Why This Matters
Before a new clinic can bill Medicare, the operating entity must register the location through PECOS, creating a record in the Practice Location Extract. A new location appearing in this quarterly file tells you the organisation is opening a new site and has begun the administrative process. The site may not be operational yet — but the leadership hiring needs to happen months in advance. A site director or clinical lead needs 8-12 weeks minimum for credentialing, equipment selection, and workflow design before go-live.
The search partner who arrives during this window frames the conversation around timeline risk: "You're opening a new oncology clinic in Q3. Your site director needs to be in place by June. Have you started that search yet?"
Roles & Who to Contact
Roles This Intelligence Triggers: Site Director/Practice Manager, Clinical Lead, Medical Director, Lead RN.
Who to Approach: VP of Ambulatory Operations, VP of Practice Management, or the executive sponsor of the new site.
How to Track It
Download the CMS Practice Location Extract quarterly from data.cms.gov. Compare against the previous quarter — any new address associated with an existing enrolled entity is a potential stealth launch. Filter by geography and facility type. The comparison takes 3-4 hours quarterly; the main challenge is address formatting variations between filings.
Check whether the parent organisation has stuck roles elsewhere (Intelligence 5). An organisation opening a new site AND struggling to fill existing leadership positions is under-resourced on talent acquisition.
When 10+ physicians at a practice simultaneously change their billing entity in CMS data, it usually means a private equity group has acquired the practice. These acquisitions happen quietly and create a wave of integration, operational leadership, and physician management roles.
Why This Matters
PE firms acquire physician practices and consolidate them under new management entities. These deals are often structured as asset purchases — no press release, no Becker's article. But CMS enrollment data tells the story: mass billing reassignment to a new entity is the PE roll-up fingerprint. The acquiring entity needs integration managers, operational directors, and often a regional medical director. The existing managing partners frequently transition to purely clinical roles or depart, creating additional leadership vacancies.
Roles & Who to Contact
Roles This Intelligence Triggers: Regional Medical Director, VP of Operations (multi-site), Practice Administrator, Integration Project Director, VP of Medical Affairs.
Who to Approach: The acquiring entity's CEO, COO, or VP of Practice Management.
How to Track It
Compare the CMS Physician and Other Practitioners file quarterly. Identify groups of 10+ providers at the same practice who simultaneously moved to a new billing entity. This pattern — mass reassignment — is the PE roll-up indicator. The quarterly processing takes 4-5 hours; the challenge is identifying which new entities are PE-backed.
Check LinkedIn for departures of managing partners (Intelligence 6). Departures within 60 days of a detected PE roll-up confirm integration is creating leadership turnover.
When a hospital or ASC adds operating rooms, increases bed count, or pivots to advanced surgical specialties, the expansion is recorded in federal facility data. More surgical capacity means more clinical leadership — and you can detect it months before hiring begins.
Why This Matters
CMS tracks facility characteristics including bed count, OR count, and service capabilities through the POS file and iQIES. When a facility adds 20 beds or an ASC upgrades from basic procedures to advanced specialties (total joint, spine, cardiac catheterisation), the change appears quarterly. Physical capacity expansion creates non-negotiable hiring needs — you cannot open a new OR without a team, cannot add 30 beds without nursing leadership. The capital expenditure is committed; leadership hiring is the final step.
Roles & Who to Contact
Roles This Intelligence Triggers: OR Director, Perioperative Nursing Director, Surgical Services Director, ASC Administrator, Chief of Surgery, Anesthesia Director.
Who to Approach: CNO (nursing leadership), Chief of Surgery or VP of Surgical Services, ASC Administrator.
How to Track It
Download the CMS POS file quarterly (same file as Intelligence 7). Compare bed counts, OR counts, and registered service capabilities against the previous quarter. Flag any facility with increases. This analysis is combined with Intelligence 7 processing — 2-3 hours total per quarter.
Check for CON filings (Intelligence 13) and new leader arrivals (Intelligence 9). Capacity expansion often coincides with new surgical or operational leadership who will be building their team.
In roughly 35 US states, a Certificate of Need is legally required before a hospital can add beds, build facilities, or launch new service lines. This indicator has two phases: the filing (public the moment it's submitted — 3-6 months before approval) and the approval (capital committed, expansion guaranteed). Both are public. Both create hiring conversations. The search partner who starts at filing stage and follows through to approval has been tracking the project longer than anyone else in the room. You can find the full list of CON states here.
Why This Matters
CON applications describe the project, its costs, timeline, and community need — all publicly filed with the state health department. At filing stage, the facility has completed capital planning and secured board approval. They know they need leadership to execute the expansion but haven't started searching — they're focused on getting the CON approved. The conversation at this stage is naturally consultative: "I saw your application for the new cardiac wing — I work with clinical leadership in this space and wanted to understand your timeline." No facility ignores that call.
At approval stage, the capital is fully committed and the expansion is guaranteed. Leadership hiring must happen 6-9 months before go-live — a cardiac service line director needs time for program design, physician credentialing, and payer contracts. Because CON filings are state-level documents that most search partners never check, the competitive advantage at both stages is substantial.
The search partner who arrives at filing and re-engages at approval has continuity no competitor can match. You're not cold-pitching — you're the search partner who's been tracking their project since the first public filing.
Roles & Who to Contact
Roles This Intelligence Triggers: Depends on project type. Cardiac wing: Cardiac Service Line Director, Cath Lab Manager, ICU Nursing Director. Cancer center: Oncology Service Line Director. Bed expansion: Nursing Directors, Unit Managers.
Who to Approach: VP/SVP of the relevant service line, COO, or VP of Capital Projects.
How to Track It
Check state health department CON databases monthly for your target geography. Around 35 states have active CON programs — Virginia, North Carolina, Georgia, and Florida have well-organized searchable databases; others require manual review. Track both new filings (Phase 1) and recent approvals (Phase 2). Focus on filings involving bed expansion, new service lines, or new facility construction. Effort varies: 15-30 minutes per well-organized state, up to an hour for others.
When a filing appears, set a calendar reminder to re-check for approval status monthly. When approval comes, re-engage with updated timing context — you're now the search partner who's been tracking this project since it was first filed.
Cross-reference with Intelligence 14 for double confirmation. Also check whether the facility recently hired a new service line leader (Intelligence 9) — they're likely the person driving the expansion hiring.
When a hospital publicly announces an expansion — press release, local news, investor communication — it confirms the project is approved, funded, and moving forward. In the ~15 states without CON requirements, this may be the earliest indicator available. In CON states, it serves as confirmation and timing update.
Why This Matters
Significant expansions generate public attention — new hospital towers, ambulatory campuses, urgent care chains require community engagement and often public financing. The announcement comes after board approval and secured financing, but before operations begin. The hiring logic is identical to Intelligence 13: capital is committed, leadership must be in place well ahead of go-live. The value is highest in non-CON states (Texas, California, Colorado, Kansas, Pennsylvania, and others) where no regulatory filing catches the expansion early.
While this data is publicly available, putting it together consistently — combining news monitoring with CMS facility data, leadership changes, and stuck role overlays — is what creates the compound intelligence no single Google Alert can match.
Roles & Who to Contact
Roles This Intelligence Triggers: Same as CON-related expansions: Service Line Directors, Department Heads, Nursing Directors, OR Directors.
Who to Approach: Service line VP, COO, or project sponsor.
How to Track It
Set up Google Alerts for healthcare expansion keywords in your target geography: "hospital expansion," "new hospital wing," "[specific hospital names] expansion." Review alerts daily — 10-15 minutes. When announced, note the project scope, timeline, and facility leadership. Set follow-up reminders for the hiring window.
Immediately cross-reference with all other intelligence. Layer it with CMS facility data (Intelligence 12), leadership changes (Intelligence 9), and stuck roles (Intelligence 5). That layered picture is what separates a intelligence-led search partner from someone who read an article and sent a cold email.
Highest value for agencies placing physicians and clinical directors in community health, rural hospitals, and FQHCs. If your agency doesn't recruit in these settings, this intelligence may not be relevant.
When HRSA designates an area or facility as a Health Professional Shortage Area, it unlocks federal funding and expansion programs that require leadership hiring. Rural hospitals, FQHCs, and community health centres in newly designated HPSAs are expanding — often with ring-fenced federal money — and almost no executive search firms are monitoring this data.
Why This Matters
HRSA HPSA designations come with funding eligibility: National Health Service Corps placements, HRSA grants, and enhanced Medicare/Medicaid reimbursement. A facility with a new or upgraded designation is actively positioning to grow clinical capacity. A rural hospital adding primary care needs a Medical Director. An FQHC expanding into behavioral health needs a Clinical Director. These are permanent, senior, placement-worthy roles.
The competitive advantage is significant. Larger search firms don't focus on rural health or FQHCs — the deal size feels small to them. But for a executive search firm doing physician or clinical leadership placement, a newly funded FQHC or rural hospital is a motivated buyer with real money and almost no existing search partner relationships.
Roles & Who to Contact
Roles This Intelligence Triggers: Medical Director, CMO, Chief of Primary Care, Director of Nursing, Behavioral Health Director, Clinical Operations Director.
Who to Approach: CEO or Executive Director of the FQHC or rural health system. These organisations are founder or CEO-led — skip HR entirely.
How to Track It
HRSA publishes the full HPSA database at data.hrsa.gov — downloadable and updated quarterly. Filter by designation type (Primary Care, Mental Health), status (Newly Designated), and geography. Compare quarter-over-quarter to identify new designations or score changes. Takes 1-2 hours quarterly once the comparison workflow is set up.
Cross-reference with Intelligence 5 (Stuck & Reposted). A newly designated FQHC or rural hospital that is also advertising a Medical Director role with no fill after 45 days is already feeling the shortage — and the federal designation just confirmed it. That's the moment to call.
SAMHSA awards grants to community mental health centres, addiction treatment providers, and crisis service organisations on a continuous basis. A new grant means ring-fenced federal funding for program expansion — new services, new capacity, new clinical leadership needed to run it. Published on SAMHSA's website and grants.gov in real time. The organisation has the money before they know who to hire.
Why This Matters
Behavioral health organisations are chronically underfunded relative to demand. A SAMHSA grant — whether a Certified Community Behavioral Health Clinic grant, a State Opioid Response grant, a Mental Health Block Grant award, or a targeted capacity expansion grant — represents a material change in what the organisation can afford to do. The grant often comes with requirements: minimum staffing levels, specific program deliverables, reporting structures. Meeting those requirements means hiring leadership that doesn't currently exist.
The competitive advantage here is timing. The organisation receives the grant award notice months before they post a single job. They are internally discussing what the expansion looks like, what leadership they need, and how to spend the money. A search partner who arrives at grant award stage is having a strategic conversation, not responding to a job posting. That positioning is almost impossible to replicate once the role goes live.
Roles & Who to Contact
Roles This Intelligence Triggers: Chief Clinical Officer, Program Director, Director of Addiction Services, Medical Director, VP of Operations, Director of the specific funded program (e.g. Director of Crisis Services for a crisis expansion grant).
Who to Approach: CEO or Executive Director of the organisation. At grant award stage, the CEO is the person planning the expansion — they are not yet talking to HR about hiring because the org chart hasn't been drawn yet. That's exactly when you want to be in the conversation.
How to Track It
SAMHSA publishes grant awards on samhsa.gov under the Grants section, updated continuously. Cross-reference with grants.gov — search by agency (SAMHSA) and filter by award date. Both databases are free and fully searchable by state, award amount, and grant program. Filter for private non-profit and for-profit organisations rather than state agencies — those are the founder-led and PE-backed operators that match your ICP. Set up a weekly Exa.ai search for "SAMHSA grant award behavioral health [state] 2026" to catch press coverage of significant awards that surfaces faster than the database updates. Takes 1-2 hours per week across both sources.
The chain from grant award to job order is longer than a distress indicator — typically 60-120 days. The advantage is that you arrive before any other search partner and can shape the role specification in conversation with the CEO. Frame your outreach around the grant program specifically: "I saw you received the CCBHC expansion grant — I work with behavioral health organisations building out clinical leadership for exactly this kind of capacity expansion." That level of specificity demonstrates you understand their world.
Cross-reference with Intelligence 31 (1115 Waiver). An organisation that receives a SAMHSA grant in a state that has also just received a 1115 waiver expanding behavioral health Medicaid coverage is sitting at the intersection of federal grant funding and expanded reimbursement — a rare double tailwind that almost always triggers significant leadership hiring. That combination is your highest-priority behavioral health growth account.
When CMS approves a state's 1115 Medicaid waiver that expands behavioral health coverage — which has been happening at scale post-COVID — every behavioral health provider in that state gains access to a significantly larger reimbursable population. Organisations that were previously cash-constrained can now fund clinical leadership they couldn't afford before. The waiver approval is public, the implementation timeline is known, and the hiring wave is predictable months in advance.
Why This Matters
A 1115 waiver is a federal approval that allows a state to test new Medicaid approaches outside standard rules. Post-2020, CMS has approved a wave of waivers specifically expanding behavioral health Medicaid coverage — extending eligibility, adding new covered services, funding community-based mental health and addiction treatment at scale. For behavioral health providers in the approving state, this is a structural change in their revenue model, not a one-time grant.
The organisations best positioned to capture the expanded Medicaid population are those that can scale their clinical capacity fast. That means hiring: more clinicians, yes, but also the clinical leadership infrastructure to manage them — CCO, Medical Director, VP of Clinical Operations, Regional Clinical Directors. The waiver creates a multi-year expansion mandate with a known start date. That gives you a longer and more predictable targeting window than almost any other indicator in this playbook.
Roles & Who to Contact
Roles This Intelligence Triggers: Chief Clinical Officer, Medical Director, VP of Clinical Operations, Regional Clinical Director, Director of Outpatient Services, Director of Community Behavioral Health.
Who to Approach: CEO or COO of behavioral health provider organisations in the state. The right targets are mid-size providers — large enough to scale but not so large they have an internal talent acquisition function. Founder-led organisations that have been operating below their potential due to Medicaid reimbursement limits are the highest-priority accounts.
How to Track It
CMS publishes all approved 1115 waivers on medicaid.gov under the Waivers & Demonstrations section — searchable by state and waiver type, updated as approvals are issued. Filter specifically for waivers with behavioral health, mental health, or substance use disorder components. Once a waiver is approved, identify the implementation date — typically 6-12 months after approval — and work backward to time your outreach. Supplement with Exa.ai running a monthly search for "1115 waiver behavioral health Medicaid approved [state] 2026" to catch state health department announcements and trade press coverage. Takes 1-2 hours monthly once the CMS page is bookmarked.
This indicator works differently from the others — it targets a cohort of organisations in a state rather than a single facility. When a 1115 waiver is approved, build a list of the 10-20 behavioral health providers in that state most likely to expand. Rank them by size, founder-led status, and current leadership gaps (check LinkedIn). Work that list systematically over the following 3-6 months. One waiver approval can generate multiple conversations across multiple organisations.
Cross-reference with Intelligence 17 (HRSA Shortage Designation). A state with a new 1115 behavioral health waiver AND multiple HPSA designations for mental health shortage areas is experiencing systemic behavioral health capacity failure at both the federal and state level simultaneously. Providers in that state are about to receive more funding and more patients than they have ever managed before. That is your highest-conviction behavioral health growth market.
CMS publishes quality ratings for every Medicare-certified hospice on Hospice Compare, updated quarterly. A rating drop indicates clinical quality failures that are now visible to the hospitals, oncologists, and primary care physicians who control referral streams. Hospices run on referrals. A visible quality decline triggers an internal review of clinical leadership before referral partners make the decision for them by switching to a competitor.
Why This Matters
Hospice is a referral-dependent business. A hospital discharge planner choosing between two hospices will check Hospice Compare. An oncologist recommending end-of-life care to a patient's family will check Hospice Compare. A rating drop is therefore not just a quality metric — it is a commercial threat. Referral partners who see a declining rating start hedging their referrals toward competitors. Census drops within one to two quarters of a visible rating decline.
The Executive Director of a hospice watching their Hospice Compare rating fall knows exactly what is coming. The internal response is to review the clinical quality drivers — which points directly at the Chief Clinical Officer and the Director of Clinical Services. Unlike distress indicators where the urgency is regulatory, this indicator creates commercial urgency: fix the quality leadership before the referral relationships deteriorate beyond repair. That commercial framing gives you a different and often more resonant outreach angle than regulatory pressure alone.
Roles & Who to Contact
Roles This Intelligence Triggers: Chief Clinical Officer, Director of Clinical Services, Director of Quality, Medical Director of Hospice.
Who to Approach: Executive Director or CEO. Frame the conversation around referral relationship protection and census stability — the commercial consequences of a quality rating drop — rather than regulatory compliance. This buyer responds to business language more than regulatory language.
How to Track It
CMS publishes Hospice Compare quality data as a downloadable dataset on data.cms.gov — updated quarterly. Download the dataset, compare current ratings against the previous quarter, and flag any hospice that has dropped on the overall quality score or on specific measures. Filter by geography and organisation size — focus on independent and small PE-backed operators where the leadership team is small enough that a quality failure points directly at a named individual. Takes 1-2 hours quarterly once the comparison workflow is built.
Cross-reference with Intelligence 32 (CMS Condition-Level Deficiency). A hospice with both a rating drop and an open Condition-level deficiency is failing on quality measurement and regulatory compliance simultaneously — and both are visible to referral partners who check Hospice Compare and CMS survey data before directing patients. That compound indicator elevates this from a ★★★ growth conversation to a ★★★★★ distress conversation. Lead with the regulatory finding and the rating drop confirms the commercial stakes.
Private equity is consolidating the hospice sector at significant pace. When a PE firm acquires an independent hospice or adds to an existing platform, the 90-180 day post-acquisition window almost always involves leadership transition — either the existing team is replaced to fit the PE operating model, or new leadership is added above the existing team to drive the PE thesis. Acquisition announcements are public. The leadership change window is predictable. Almost no search partners track hospice M&A systematically.
Why This Matters
PE-backed hospice consolidation follows a consistent playbook. The acquiring firm buys a founder-led operator, installs a professional management layer above the existing clinical team, and drives growth through geographic expansion, referral network development, and operational standardisation. This almost always means new leadership: a CEO or Executive Director who understands PE operating environments, a CCO who can build scalable clinical systems, and a VP of Operations who can manage multi-site growth.
The founder who built the hospice typically either exits at acquisition or stays in a clinical role while professional operators take over the business functions. Either way, the leadership structure changes materially within the first 90-180 days. The acquisition announcement is your indicator. The 90-day mark is your window. Most search partners don't track hospice M&A at all — the ones who do own the relationship before the PE firm has even posted a role.
Roles & Who to Contact
Roles This Intelligence Triggers: Executive Director, Chief Clinical Officer, VP of Operations, Chief Growth Officer, Regional Director of Operations, Medical Director of Hospice.
Who to Approach: PE operating partner or the newly appointed platform CEO — not the acquired hospice's founder, who may be exiting or transitioning. Identify the PE firm, find the operating partner responsible for the healthcare portfolio, and approach at that level. They are building a leadership team, not filling a vacancy.
How to Track It
Hospice M&A is covered by Hospice News, McKnight's Home Care, Home Health Care News, and Irving Levin Associates' healthcare M&A reports. Set up Exa.ai running a weekly search for "hospice acquisition private equity 2026" to surface deals across all these sources simultaneously. Supplement with Google Alerts for specific PE firms known to be active in hospice consolidation. LinkedIn is also valuable — PE operating partners in healthcare announce platform acquisitions on their profiles. Takes 30-45 minutes per week to monitor across these sources.
This intelligence is categorised as Event-Based rather than Distress or Growth because the trigger is a structural change in ownership — not a failure or an expansion. The hiring pressure it creates is real but the motivation is different: the PE firm is building a leadership team to execute a value creation thesis, not filling a gap caused by a crisis. Your outreach framing should reflect that — lead with growth and scale language, not problem-solving language. "I work with hospice operators building leadership teams for PE-backed growth platforms" lands differently than "I saw you had a leadership gap."
Track the PE firm's broader hospice portfolio, not just the acquired organisation. PE firms building hospice platforms make multiple acquisitions — if you place well into one acquisition, you become the natural first call for the next one. Build the relationship at the operating partner level, not the portfolio company level, and one placement can generate a pipeline of mandates across the entire platform build.
Detecting intelligence is half the job. The other half is turning it into a conversation. Lead with value before asking for anything, match your value asset to the specific intelligence, and make it personal enough that the recipient knows you've done your homework.
The Three-Part Fix
Right timing. Intelligence-led outreach arrives when a specific operational pressure exists — a penalty, a vacancy, an expansion. The hiring manager cares because they have a problem right now.
Specific reference. You reference the specific situation at their specific facility. It tells them you've done something 99% of search partners won't do.
Value upfront. You lead with something genuinely useful — a talent market insight, a candidate snapshot, a salary benchmark — before asking for anything.
Match the Value Asset to the Intelligence
Distress intelligence: Lead with candidate availability. When a facility has a stuck role or sudden vacancy, the most valuable thing you can show is that you already have relevant candidates mapped. Three passive profiles matched to their exact role, seniority, and geography.
Performance intelligence: Lead with market intelligence. Ownership changes and new leaders don't have specific vacancies yet — they have structural shifts creating them. Share what roles typically emerge, what candidate availability looks like, and how long searches take.
Growth intelligence: Lead with time-to-hire benchmarks. Expanding facilities have a go-live date. What they often lack is realistic understanding of how long senior clinical hiring takes. A note that says "oncology service line director searches are taking 90-120 days — if you need someone by Q3, the search starts now" gives them immediately useful planning information.
Make It Personal
Name the intelligence. "I saw your hospital was flagged in the latest CMS readmission data." One sentence. Instantly separates you from every generic search partner.
Acknowledge the pressure. "Facilities in this position typically prioritise case management leadership — and the talent pool in your region is competitive."
Offer the asset. "I put together a candidate availability snapshot for your region — happy to share if useful."
Make response effortless. "Just reply Yes." One word. Zero friction.
Email Templates
Subject: hiring plans after [Hospital]'s CMS results?
[First Name], I noticed [Hospital] appeared in the latest [HAC/HRRP] results — the penalty pressure on [metric area] is something several facilities in your region are dealing with right now.
Facilities in this position typically move quickly on [Quality Director / Case Management Director] leadership. The candidate pool for these roles in [region] is thin right now.
I've put together a candidate availability snapshot for [role type] in your area.
Just say Yes.
Subject: still hiring that [Role Title]?
[First Name], your [Role Title] has been live for about [X] weeks — not unusual for this level right now.
When a search runs this long, the issue is usually where it's focused rather than the brief itself. Most of the strongest candidates aren't on the job boards.
I've mapped where the best passive [specialty] candidates are right now, including three profiles not publicly looking.
Want to see them? Just reply Yes.
Subject: team plans after [event]?
[First Name], I saw [Facility] recently [completed an ownership transition / appointed an Interim CNO].
Transitions like this typically create leadership hiring needs in the first 90-180 days — and the window tightens quickly.
I've put together a note on what integration hiring typically looks like at this stage, plus candidate availability for the roles that emerge first.
Can I share it?
Subject: hiring plans for [Facility]'s expansion?
[First Name], I saw [Facility]'s [CON approval / expansion announcement / new site registration].
Expansions at this scale typically need [X] clinical leadership hires in the first 6-9 months, and the [specialty] talent pool in your region is competitive right now.
I've put together a salary benchmark and candidate availability snapshot for the roles this expansion will likely need.
Want it? Just say Yes.
Finding Contact Details
At this point you know the intelligence, you know the facility, and you know the role title you need to reach — a CNO, a VP of Quality, a Clinical Director. What you don't know yet is who that person actually is: their name, their exact title, whether they're still in the role, and how to get a verified email or phone number. That's what this section covers.
For contact and email discovery: Apollo is the broadest database and a good starting point. Prospeo works well as a supplement when Apollo misses — it runs real-time email pattern matching. ai-ark.com is particularly useful for healthcare contacts because it pulls from multiple sources simultaneously, filling gaps other tools miss.
For verification: FullEnrich runs contacts through multiple enrichment sources in parallel. BetterContact is strong on verification — confirming the email is active, not just formatted correctly. Running your list through verification before sending protects your domain reputation.
The workflow: Discover with Apollo → supplement gaps with Prospeo or ai-ark → verify through FullEnrich or BetterContact. If two tools can't find a verified contact for someone, move to the next person at the same facility. The intelligence stays the same. The recipient can flex.
Domain & Email Setup
If you've looked into outbound before — or read about it online — you've probably been told you need five domains, a dozen email accounts, complex DNS records, SPF and DKIM authentication chains, and weeks of warmup before you can send anything. That advice is built for high-volume spray-and-pray outbound where you're blasting 500+ emails per week and need to distribute volume across infrastructure to avoid spam filters.
Intelligence-led outreach is the opposite. You're sending 15-30 highly personalised, intelligence-referenced emails per week to people who have a specific, verified reason to engage. At that volume, your primary domain and existing business email are fine.
If you want extra protection — one additional domain, two email addresses. That's the ceiling. Don't overcomplicate this. The bottleneck in intelligence-led outreach is never email infrastructure. It's intelligence detection, personalisation, and follow-up discipline.
Not everyone is active on LinkedIn. The strongest outreach uses both channels — but the channel you lead with depends on whether the prospect is actually present and engaged. Split your list, run two tracks.
The Problem With One Channel
Some CNOs and CMOs are active on LinkedIn — they post about leadership, comment on peers' content. These people are reachable through engagement before you ever send an email. Other healthcare executives haven't posted in six months. Sending them a LinkedIn message is shouting into a void. The mistake is treating everyone the same.
How to Tell If Someone Is Active
An "active" user means someone who posted original content within the last 30 days. Not job ads. Not company reshares. Commentary, opinions, industry reactions. You can check manually — but for a list of 200 people, it's not practical.
I've built a free tool that checks LinkedIn activity across your entire prospect list. Bring your own Apify API key, upload your list, and it returns who's active and who isn't — giving you a clean split.
LinkedIn Track (prospect IS active)
Week 1-2: Engage with 2-3 of their recent posts. Substantive comments, not "great post!" The goal is name recognition.
Week 2-3: Connection request with a short, intelligence-relevant note. No pitch.
Week 3-4: Your intelligence-led message as a LinkedIn DM. Same structure as the email templates.
No response by Week 4: Move to email with the same intelligence-led message.
Email Track (prospect is NOT active)
Day 1: Intelligence-led email using the templates from Part IV.
Day 3-4: Short follow-up. "Just checking if the [value asset] would be useful."
Day 7-8: LinkedIn connection request referencing the email.
Day 14: Final follow-up email with a different intelligence angle on the same facility.
After this sequence with no response, move to a nurture list. When new intelligence fires on the same facility, re-engage with fresh context.
The intelligence does the heavy lifting. The channel is just delivery. Don't optimise for channel tactics — optimise for intelligence relevance. The channel gets the message there. The intelligence gets the reply.
You don't need to run all 34 intelligence entries from day one. Find your specialism in Part II and start with the 2-3 highest-rated intelligence entries listed there. Build the rhythm until it's automatic, then layer on more. Running three intelligence entries consistently beats running twelve inconsistently. Start narrow, go deep, expand when it's easy.
The Overwhelm Trap
You've just read 34 intelligence entries across four categories. If your instinct right now is "there's no way I can track all of this," that's the right instinct — and it's the wrong conclusion.
You're not supposed to run all 34 from a standing start. The guide gives you the full map so you can see what exists. Your job is to pick the corner of the map that fits your agency, your specialisms, and your available hours — and work that corner until the operating rhythm is second nature.
A 10-person agency placing nursing directors into hospital systems doesn't need to track 340B audit violations or PE roll-ups. They need Intelligence 5 (Stuck & Reposted), Intelligence 6 (Leadership Exit), and Intelligence 2 (Medicare Penalty). Three intelligence entries. That's a 3-4 hour weekly commitment. Entirely manageable alongside a full delivery workload.
Pick Your Starting Set
If you have 2-3 hours per week: Start with two intelligence entries. Intelligence 5 (Stuck & Reposted) is the universal starting point — it works for every specialism. Pair it with one that matches your niche using Part II as your guide.
If you have 5-7 hours per week: Add the daily monitoring layer: Intelligence 6 (Leadership Exit) and Intelligence 8 (Interim Leader). 15-20 minutes per day catching pre-market vacancies. You're now running four intelligence entries.
If you have 8+ hours per week (or a dedicated BD person): Add the quarterly CMS data intelligence, CON filings, and news monitoring. Layer in specialised intelligence that matches your niche. 8-12 intelligence entries generating 30-50 intelligence-qualified targets per month.
The Rule of Three
When starting, cap yourself at three active intelligence entries. Track them for 30 days. Run the full cycle: detect, research, stack, draft outreach, send, follow up. After 30 days, drop the entry that isn't producing and add a new one. The agencies that get the most from this guide aren't the ones who try to track everything. They're the ones who pick the right three intelligence entries, run them with discipline, and expand only when the rhythm is effortless.
The Weekly Operating Rhythm
Knowing which intelligence to track is one thing. Running them consistently is what separates a system from an experiment. Here's the cadence, the prioritisation framework, and a fully worked example.
The Cadence
Daily (15-20 min): Google Alerts for expansion news (Intelligence 14). LinkedIn notifications for leadership changes (Intelligence 6, 8, 9). Time-sensitive — value decays within days.
Weekly (45-60 min): LinkedIn Jobs for stuck and reposted roles (Intelligence 5). Bond rating and DOJ monitoring via Exa.ai (Intelligence 19, 23). SAMHSA and hospice news via Exa.ai (Intelligence 28, 32, 34, 35). Your highest-volume intelligence work.
Monthly (2-3 hours): OIG LEIE exclusion updates (Intelligence 1). CMS IJ citations (Intelligence 15). State CON database reviews (Intelligence 13). REH conversions (Intelligence 20). State behavioral health and hospice license actions (Intelligence 29, 33). State pharmacy board actions (Intelligence 27).
Quarterly (4-6 hours): CMS POS file for ownership changes and bed/OR changes (Intelligence 7, 12). Practice Location Extract for new sites (Intelligence 10). Provider enrollment data for PE roll-ups (Intelligence 11). HRSA HPSA designations (Intelligence 16, 31). 340B audit findings (Intelligence 21). Five-Star rating changes (Intelligence 22, 36). SAMHSA grant awards (Intelligence 30). USP and Joint Commission findings (Intelligence 24, 25). Hospice Compare data (Intelligence 36).
Annual (3-4 hours, October): CMS HAC results (Intelligence 2). CMS HRRP results (Intelligence 3). IPFQR data (Intelligence 4).
How to Prioritise
When multiple indicators fire, prioritise by layer depth × urgency.
Work immediately: Any distress indicator layered with at least one other indicator. Stuck role at a penalised hospital. Leadership exit during an ownership change. IJ citation at a facility with open roles.
Work this week: Single high-urgency distress indicators. Performance intelligence with layering.
Work within 2-4 weeks: Growth intelligence with layering. Quarterly CMS findings. CON approvals with near-term completion.
Nurture list: Single growth indicators without layering. New leader arrivals without other indicators.
Worked Example: From Intelligence to Retained Mandate
Week 1 — Detection. October. CMS penalty data publishes. You filter for Texas, 200+ bed hospitals. Memorial Regional Medical Center in Houston appears — penalised for safety failures, elevated SSI and CLABSI rates.
Week 1 — Stacking. You check Memorial Regional on LinkedIn. Their Director of Quality and Patient Safety role has been open 52 days (Intelligence 5). A new CNO joined three months ago from a system where she led a quality turnaround (Intelligence 9). The Infection Prevention Director updated her title eight weeks ago to show a new employer (Intelligence 6) — and the role hasn't been posted.
Four indicators layered: CMS penalty + stuck quality role + new CNO + unposted IP Director vacancy.
Week 1 — Outreach. You email the new CNO:
Subject: quality leadership at Memorial Regional
[CNO First Name], congratulations on joining Memorial Regional — I noticed you came from [Previous System], where quality metrics improved significantly during your tenure.
Memorial Regional appeared in the latest HAC results with elevated SSI and CLABSI rates, and the Director of Quality search has been running for almost eight weeks. Facilities in this position typically need to move fast on both quality and infection prevention leadership.
I've mapped the Quality Director and Infection Prevention Director talent market in the Houston region — including three passive candidates with HAC turnaround experience.
Would it be useful to see the market map? Just reply Yes.
Week 2. The CNO replies: "Yes, please send it over." You send candidate profiles and a market snapshot. You suggest a 15-minute call.
Week 3. On the call, the CNO confirms she was hired to fix quality metrics. The IP Director role hasn't been posted — they need someone in 60 days. She asks if you can run both searches. You propose retained for the IP Director (pre-market, confidential) and exclusive contingency for the Quality Director (posted but failed internally). She agrees to both.
The timing was right (2 weeks after CMS publication). The message was specific (exact penalty data, exact stuck role, exact leadership change). The value was upfront (candidate map, not a pitch). And the layered intelligence gave insight no other search partner had. That's the difference between contingency and retained.
Your Move
Everything in this guide describes real, trackable hiring intelligence across healthcare — the kind of predictive executive search business development intelligence that no job board, referral network, or conference relationship can match. The intelligence is there. The question is whether you want to track it yourself — or have it delivered to your desk.
Request a free intelligence brief for your desk. Delivered to your inbox within 24 hours.
Tell us your specialism and geography. We'll produce a desk-level intelligence brief — real intelligence, real facilities, real hiring pressure — so you can see exactly what this looks like for your market.
We are not a search firm. We do not compete with you. We produce the intelligence that helps you win.
Request a Free Brief Book a Callforesightbridge.com — Kawsar Alam